Harry McNaughton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Harry McNaughton has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Peter Alan Barber
University of Auckland
9 shared publications - Annemarei Ranta
Department of Medicine, University of Otago, Wellington, New Zealand
7 shared publications - John Gommans
Hawkeʼs Bay Hospital, Hastings, New Zealand (J.G.).
7 shared publications Mark Weatherall
University of Otago
7 shared publicationsVivian Fu
Stroke/Rehabilitation, Medical Research Institute of New Zealand, Wellington, New Zealand
7 shared publications- Valery L. Feigin
Auckland University of Technology
6 shared publications
Latest Publications
- 1 January 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (1) , 20-26
Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial
BACKGROUND: The Take Charge intervention—a conversation-based, community intervention to improve motivation, improved independence, and physical health 12 months after stroke in 2 randomized controlled trials with 572 participants. This article reports long-term outcomes for the 400 participants in the TaCAS study (Taking Charge After Stroke). METHODS: Follow-up study of a New Zealand multicenter, randomized, controlled, parallel-group trial. Outcomes were collected by postal questionnaire or telephone call. The TaCAS study recruited 400 participants discharged after stroke, randomized within 16 weeks to one of 3 groups: 1 session of the Take Charge intervention, 2 sessions 6 weeks apart, or no sessions (control). This study is of participants still alive and willing to answer a questionnaire 5 to 6 years after their index stroke, undertaken in 2022. The primary outcome was the Physical Component Summary of the Short Form 36, comparing the Take Charge intervention and control. Secondary outcomes were: Frenchay Activities Index; modified Rankin Scale (mRS); survival; and stroke recurrence. These outcomes were compared with those 12 months after stroke. Analysis was by ANOVA or logistic regression. RESULTS: Mortality data were available for all 400 participants, and functional data for 204/297 (69%) of survivors. The mean difference (95% CI) in Physical Component Summary between Take Charge and control groups was 2.8 (−0.8 to 6.5) units, P =0.12, and for independence (modified Rankin Scale score, 0–2) the odds ratio (95% CI) was 0.56 (0.28–1.16), P =0.11, both favoring Take Charge with similar point estimates to those after 12 months. Differences between Take Charge and control participants for Frenchay Activities Index scores, survival, and stroke recurrence were small and nonsignificant. CONCLUSIONS: The clinically significant improvements in physical health and independence for Take Charge participants, observed at 12 months, were sustained 5 to 6 years after stroke, but no longer statistically significant. REGISTRATION: URL: https://anzctr.org.au ; Unique identifier: ACTRN12622000311752.
- 1 January 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (1) , 20-26
Long-Term Follow-Up of Participants in the Taking Charge After Stroke Randomized Controlled Trial
BACKGROUND: The Take Charge intervention—a conversation-based, community intervention to improve motivation, improved independence, and physical health 12 months after stroke in 2 randomized controlled trials with 572 participants. This article reports long-term outcomes for the 400 participants in the TaCAS study (Taking Charge After Stroke). METHODS: Follow-up study of a New Zealand multicenter, randomized, controlled, parallel-group trial. Outcomes were collected by postal questionnaire or telephone call. The TaCAS study recruited 400 participants discharged after stroke, randomized within 16 weeks to one of 3 groups: 1 session of the Take Charge intervention, 2 sessions 6 weeks apart, or no sessions (control). This study is of participants still alive and willing to answer a questionnaire 5 to 6 years after their index stroke, undertaken in 2022. The primary outcome was the Physical Component Summary of the Short Form 36, comparing the Take Charge intervention and control. Secondary outcomes were: Frenchay Activities Index; modified Rankin Scale (mRS); survival; and stroke recurrence. These outcomes were compared with those 12 months after stroke. Analysis was by ANOVA or logistic regression. RESULTS: Mortality data were available for all 400 participants, and functional data for 204/297 (69%) of survivors. The mean difference (95% CI) in Physical Component Summary between Take Charge and control groups was 2.8 (−0.8 to 6.5) units, P =0.12, and for independence (modified Rankin Scale score, 0–2) the odds ratio (95% CI) was 0.56 (0.28–1.16), P =0.11, both favoring Take Charge with similar point estimates to those after 12 months. Differences between Take Charge and control participants for Frenchay Activities Index scores, survival, and stroke recurrence were small and nonsignificant. CONCLUSIONS: The clinically significant improvements in physical health and independence for Take Charge participants, observed at 12 months, were sustained 5 to 6 years after stroke, but no longer statistically significant. REGISTRATION: URL: https://anzctr.org.au ; Unique identifier: ACTRN12622000311752.
- 1 December 2025
- Published by BMJ in Practical Neurology
- Vol. 26 (5) , 449-455
Low back pain, with or without sciatica
According to the Global Burden of Disease Project (2021), back pain affects over half a billion people worldwide and is responsible for the most years lived with disability of any condition. Only a small fraction of these will ever see a neurologist, but those that do pose a range of difficulties, from attempting an accurate diagnosis to estimating prognosis and providing advice as to whether any interventions, particularly surgery, are likely to be better than the effect of time alone. There are many guidelines, mainly aimed at primary care practitioners. This article tries to provide succinct evidence-based messages for neurologists (and others in secondary care) to use with patients at different stages of back pain duration—from acute to chronic—to help in navigating some of these difficulties.
- 1 December 2025
- Published by BMJ in Practical Neurology
- Vol. 26 (5) , 449-455
Low back pain, with or without sciatica
According to the Global Burden of Disease Project (2021), back pain affects over half a billion people worldwide and is responsible for the most years lived with disability of any condition. Only a small fraction of these will ever see a neurologist, but those that do pose a range of difficulties, from attempting an accurate diagnosis to estimating prognosis and providing advice as to whether any interventions, particularly surgery, are likely to be better than the effect of time alone. There are many guidelines, mainly aimed at primary care practitioners. This article tries to provide succinct evidence-based messages for neurologists (and others in secondary care) to use with patients at different stages of back pain duration—from acute to chronic—to help in navigating some of these difficulties.
- Open Access
Long term follow-up of participants in the Taking Charge after Stroke randomised controlled trial
Background The Take Charge intervention – a conversation-based, community intervention to improve motivation, improved independence and physical health 12 months after stroke in two randomised controlled trials with 572 participants. This paper reports long term outcomes for the 400 participants in the Taking Charge After Stroke (TaCAS) study. Method A follow-up study, of a multicentre, randomised, controlled, parallel-group trial. Outcome measures were collected by postal questionnaire or by telephone call. The TaCAS study recruited 400 participants discharged after stroke, randomised within 16 weeks to one of three groups: one session of the Take Charge intervention, two sessions six weeks apart or no sessions (control). This study is of participants still alive and willing to answer a questionnaire between 5 and 6 years after their index stroke. The primary outcome was the Physical Component Summary (PCS) of the Short Form 36. Secondary outcomes were: Frenchay Activities Index; modified Rankin Score (mRS); survival; and stroke recurrence. Results Mortality data were available for all 400 participants and functional data for 204/296 (69%) of survivors. The mean difference (95% CI) in PCS between Take Charge and control groups was 2.8 (−0.8 to 6.5) units, p = 0.12, and for independence (mRS 0-2) the odds ratio (95% CI) was 0.56 (0.28 to 1.16) p = 0.11, both favouring Take Charge with similar point estimates to those after 12 months. Point estimates for other outcomes also favoured Take Charge but were not statistically significant. Conclusions Differences in physical health and independence observed at 12 months, were sustained 5-6 years after stroke, but were not statistically significant.
Open AccessLong term follow-up of participants in the Taking Charge after Stroke randomised controlled trial
Background The Take Charge intervention – a conversation-based, community intervention to improve motivation, improved independence and physical health 12 months after stroke in two randomised controlled trials with 572 participants. This paper reports long term outcomes for the 400 participants in the Taking Charge After Stroke (TaCAS) study. Method A follow-up study, of a multicentre, randomised, controlled, parallel-group trial. Outcome measures were collected by postal questionnaire or by telephone call. The TaCAS study recruited 400 participants discharged after stroke, randomised within 16 weeks to one of three groups: one session of the Take Charge intervention, two sessions six weeks apart or no sessions (control). This study is of participants still alive and willing to answer a questionnaire between 5 and 6 years after their index stroke. The primary outcome was the Physical Component Summary (PCS) of the Short Form 36. Secondary outcomes were: Frenchay Activities Index; modified Rankin Score (mRS); survival; and stroke recurrence. Results Mortality data were available for all 400 participants and functional data for 204/296 (69%) of survivors. The mean difference (95% CI) in PCS between Take Charge and control groups was 2.8 (−0.8 to 6.5) units, p = 0.12, and for independence (mRS 0-2) the odds ratio (95% CI) was 0.56 (0.28 to 1.16) p = 0.11, both favouring Take Charge with similar point estimates to those after 12 months. Point estimates for other outcomes also favoured Take Charge but were not statistically significant. Conclusions Differences in physical health and independence observed at 12 months, were sustained 5-6 years after stroke, but were not statistically significant.
- Open Access
- 2 February 2025
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 39 (3) , 377-387
Coming to my own wisdom: A qualitative study exploring the role of the Take Charge intervention in stroke recovery
Objective: The Take Charge intervention, delivered early after hospital discharge following acute stroke, is effective at improving 12-month health status, independence and advanced activities of daily living. This study aims to provide a deeper understanding of the experiences of receiving Take Charge. Design: This was a qualitative study nested within a large randomised control trial, the Taking Charge After Stroke (TaCAS) study. Data were analysed using thematic analysis, and we describe our findings using interpretive description. Participants: People with stroke aged over 18 years, who were participants in the TaCAS study conducted in Aotearoa New Zealand. Intervention: Take Charge, a person-centred conversation delivered face-to-face, designed to explore a person's identity and priorities, conducted by a trained facilitator and guided by a workbook. Results: We interviewed nine participants, three from each of the three arms of the TaCAS trial – each would have received one, two, or zero Take Charge sessions (the control group). The overall theme of ‘Doing things my way/coming to know my own wisdom and expertise’ was enabled by ‘being listened to and feeling heard’ and ‘focusing on the goals which were important to me’, both strongly expressed by people who received the Take Charge intervention, and hindered by ‘medical paternalism’ and ‘loss of sense of self/“not me”’ most commonly expressed by people in the control arm. Conclusions: The Take Charge intervention empowers people with stroke by enhancing intrinsic motivation. A trusting, therapeutic relationship and non-judgemental facilitation are essential to ensure that the person feels heard.
- 2 February 2025
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 39 (3) , 377-387
Open AccessComing to my own wisdom: A qualitative study exploring the role of the Take Charge intervention in stroke recovery
Objective: The Take Charge intervention, delivered early after hospital discharge following acute stroke, is effective at improving 12-month health status, independence and advanced activities of daily living. This study aims to provide a deeper understanding of the experiences of receiving Take Charge. Design: This was a qualitative study nested within a large randomised control trial, the Taking Charge After Stroke (TaCAS) study. Data were analysed using thematic analysis, and we describe our findings using interpretive description. Participants: People with stroke aged over 18 years, who were participants in the TaCAS study conducted in Aotearoa New Zealand. Intervention: Take Charge, a person-centred conversation delivered face-to-face, designed to explore a person's identity and priorities, conducted by a trained facilitator and guided by a workbook. Results: We interviewed nine participants, three from each of the three arms of the TaCAS trial – each would have received one, two, or zero Take Charge sessions (the control group). The overall theme of ‘Doing things my way/coming to know my own wisdom and expertise’ was enabled by ‘being listened to and feeling heard’ and ‘focusing on the goals which were important to me’, both strongly expressed by people who received the Take Charge intervention, and hindered by ‘medical paternalism’ and ‘loss of sense of self/“not me”’ most commonly expressed by people in the control arm. Conclusions: The Take Charge intervention empowers people with stroke by enhancing intrinsic motivation. A trusting, therapeutic relationship and non-judgemental facilitation are essential to ensure that the person feels heard.
- 31 July 2023
- Published by BMJ in Practical Neurology
- Vol. 23 (6) , 489-492
Intrinsic motivation
The prevailing wisdom in neurological rehabilitation, and particularly for stroke, is that physical therapies are the key to improvements in function. Despite accepting the importance of ‘the motivated patient’, the lack of simple, proven ways to improve intrinsic motivation has hindered efforts to combine physical therapies with motivation. Now there is available a simple, free, well-validated approach to encourage intrinsic motivation (‘Take Charge’). The benefits for people who have had a stroke are well-established but this could be applied to people with a range of neurological and other disorders. We provide the evidential support for this approach and suggest ways of incorporating it into daily practice.
- 31 July 2023
- Published by BMJ in Practical Neurology
- Vol. 23 (6) , 489-492
Intrinsic motivation
The prevailing wisdom in neurological rehabilitation, and particularly for stroke, is that physical therapies are the key to improvements in function. Despite accepting the importance of ‘the motivated patient’, the lack of simple, proven ways to improve intrinsic motivation has hindered efforts to combine physical therapies with motivation. Now there is available a simple, free, well-validated approach to encourage intrinsic motivation (‘Take Charge’). The benefits for people who have had a stroke are well-established but this could be applied to people with a range of neurological and other disorders. We provide the evidential support for this approach and suggest ways of incorporating it into daily practice.
- Open Access
The Impact of Intensive Blood Pressure Management in the Post-Thrombolysis Setting: a real-world observational study
Introduction Systolic Blood pressure (SBP) >180mmHg following stroke thrombolysis has been associated with increased bleeding and poorer outcome. Aiming for the guideline SBP of Methods This is a prospective, single centre, sequential comparison of two blood pressure protocols. Between 2013 and 2017, the guideline based post-thrombolysis SBP target of 180 mmHg. Secondary outcomes included rate of SBP 180mmHg trended lower in the intensive group (adjusted odds ratio (aOR) 0.61; 95% CI 0.32-1.17; p=0.14). There was a higher rate of SBPs Conclusions The more intensive post-thrombolysis BP protocol led to a significant increase in sub-optimally low BP events with a non-significant trend toward fewer high BP protocol violations and unaffected patient outcomes.
Open AccessThe Impact of Intensive Blood Pressure Management in the Post-Thrombolysis Setting: a real-world observational study
Introduction Systolic Blood pressure (SBP) >180mmHg following stroke thrombolysis has been associated with increased bleeding and poorer outcome. Aiming for the guideline SBP of Methods This is a prospective, single centre, sequential comparison of two blood pressure protocols. Between 2013 and 2017, the guideline based post-thrombolysis SBP target of 180 mmHg. Secondary outcomes included rate of SBP 180mmHg trended lower in the intensive group (adjusted odds ratio (aOR) 0.61; 95% CI 0.32-1.17; p=0.14). There was a higher rate of SBPs Conclusions The more intensive post-thrombolysis BP protocol led to a significant increase in sub-optimally low BP events with a non-significant trend toward fewer high BP protocol violations and unaffected patient outcomes.
- Open Access
- 24 March 2023
- Published by SAGE Publications in International Journal of Stroke
- Vol. 18 (6) , 663-671
Ethnic differences in stroke outcomes in Aotearoa New Zealand: A national linkage study
Background: Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed. Aims: This study assessed ethnic differences in stroke outcome and service access in New Zealand (NZ) and explored underlying causes in addition to traditional risk factors. Methods: This national cohort study used routinely collected health and social data to compare post-stroke outcomes between NZ Europeans, Māori, Pacific Peoples, and Asians, adjusting for differences in baseline characteristics, socioeconomic deprivation, and stroke characteristics. First and principal stroke public hospital admissions during November 2017 to October 2018 were included (N = 6879). Post-stroke unfavorable outcome was defined as being dead, changing residence, or becoming unemployed. Results: In total, 5394 NZ Europeans, 762 Māori, 369 Pacific Peoples, and 354 Asians experienced a stroke during the study period. Median age was 65 years for Māori and Pacific Peoples, and 71 and 79 years for Asians and NZ Europeans, respectively. Compared with NZ Europeans, Māori were more likely to have an unfavorable outcome at all three time-points (odds ratio (OR) = 1.6 (95% confidence interval (CI) = 1.3–1.9); 1.4 (1.2–1.7); 1.4 (1.2–1.7), respectively). Māori had increased odds of death at all time-points (1.7 (1.3–2.1); 1.5 (1.2–1.9); 1.7 (1.3–2.1)), change in residence at 3 and 6 months (1.6 (1.3–2.1); 1.3 (1.1–1.7)), and unemployment at 6 and 12 months (1.5 (1.1–2.1); 1.5 (1.1–2.1)). There was evidence of differences in post-stroke secondary prevention medication by ethnicity. Conclusion: We found ethnic disparities in care and outcomes following stroke which were independent of traditional risk factors, suggesting they may be attributable to stroke service delivery rather than patient factors.
- 24 March 2023
- Published by SAGE Publications in International Journal of Stroke
- Vol. 18 (6) , 663-671
Open AccessEthnic differences in stroke outcomes in Aotearoa New Zealand: A national linkage study
Background: Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed. Aims: This study assessed ethnic differences in stroke outcome and service access in New Zealand (NZ) and explored underlying causes in addition to traditional risk factors. Methods: This national cohort study used routinely collected health and social data to compare post-stroke outcomes between NZ Europeans, Māori, Pacific Peoples, and Asians, adjusting for differences in baseline characteristics, socioeconomic deprivation, and stroke characteristics. First and principal stroke public hospital admissions during November 2017 to October 2018 were included (N = 6879). Post-stroke unfavorable outcome was defined as being dead, changing residence, or becoming unemployed. Results: In total, 5394 NZ Europeans, 762 Māori, 369 Pacific Peoples, and 354 Asians experienced a stroke during the study period. Median age was 65 years for Māori and Pacific Peoples, and 71 and 79 years for Asians and NZ Europeans, respectively. Compared with NZ Europeans, Māori were more likely to have an unfavorable outcome at all three time-points (odds ratio (OR) = 1.6 (95% confidence interval (CI) = 1.3–1.9); 1.4 (1.2–1.7); 1.4 (1.2–1.7), respectively). Māori had increased odds of death at all time-points (1.7 (1.3–2.1); 1.5 (1.2–1.9); 1.7 (1.3–2.1)), change in residence at 3 and 6 months (1.6 (1.3–2.1); 1.3 (1.1–1.7)), and unemployment at 6 and 12 months (1.5 (1.1–2.1); 1.5 (1.1–2.1)). There was evidence of differences in post-stroke secondary prevention medication by ethnicity. Conclusion: We found ethnic disparities in care and outcomes following stroke which were independent of traditional risk factors, suggesting they may be attributable to stroke service delivery rather than patient factors.
- Open Access
- 1 March 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 207-218
Prevention of Re-Hospitalization for Acute Exacerbations: Perspectives of People with Chronic Obstructive Pulmonary Disease: A Qualitative Study
Purpose: Current guidelines for prevention of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) reflect clinical understanding of the causes of exacerbations but with a limited recognition of person-specific contributing factors. As part of a randomized trial of a person-centered intervention aiming to promote self-determination, we describe personal perspectives of those with chronic obstructive pulmonary disease (COPD) on what they saw as the causes and best ways to stay well and prevent rehospitalization after an AECOPD. Patients and Methods: Twelve participants (mean age 69.3 years, six female, six male; eight New Zealand European, two Māori, one Pacific, and one other) were interviewed about their experiences of staying well and out of hospital. Data were collected via individual semi-structured interviews one year following an index hospital admission for AECOPD and focused on the participants’ views and experiences of their health condition, their beliefs about staying well, and the causes of and factors preventing further exacerbations and hospitalizations. Data were analyzed using constructivist grounded theory methods. Results: Three main themes were identified that described participants’ views on what helped or hindered them to stay well and out of hospital: 1) Being Positive: The importance of having a positive mindset; 2) Being Proactive: Practical steps to reduce the risk of, and consequences from, episodes of AECOPD; and 3) Being in Control: Feeling in command of one’s life and health. Each of these was affected by Being Connected: The influence of significant others, particularly close family. Conclusion: This research expands our understanding of how patients manage COPD and adds patient perspectives to current knowledge on how to prevent recurrent AECOPD. Programs which promote self-efficacy and positivity would be beneficial additions to AECOPD prevention strategies, as could the inclusion of family or significant others in wellbeing plans.
- 1 March 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 207-218
Open AccessPrevention of Re-Hospitalization for Acute Exacerbations: Perspectives of People with Chronic Obstructive Pulmonary Disease: A Qualitative Study
Purpose: Current guidelines for prevention of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) reflect clinical understanding of the causes of exacerbations but with a limited recognition of person-specific contributing factors. As part of a randomized trial of a person-centered intervention aiming to promote self-determination, we describe personal perspectives of those with chronic obstructive pulmonary disease (COPD) on what they saw as the causes and best ways to stay well and prevent rehospitalization after an AECOPD. Patients and Methods: Twelve participants (mean age 69.3 years, six female, six male; eight New Zealand European, two Māori, one Pacific, and one other) were interviewed about their experiences of staying well and out of hospital. Data were collected via individual semi-structured interviews one year following an index hospital admission for AECOPD and focused on the participants’ views and experiences of their health condition, their beliefs about staying well, and the causes of and factors preventing further exacerbations and hospitalizations. Data were analyzed using constructivist grounded theory methods. Results: Three main themes were identified that described participants’ views on what helped or hindered them to stay well and out of hospital: 1) Being Positive: The importance of having a positive mindset; 2) Being Proactive: Practical steps to reduce the risk of, and consequences from, episodes of AECOPD; and 3) Being in Control: Feeling in command of one’s life and health. Each of these was affected by Being Connected: The influence of significant others, particularly close family. Conclusion: This research expands our understanding of how patients manage COPD and adds patient perspectives to current knowledge on how to prevent recurrent AECOPD. Programs which promote self-efficacy and positivity would be beneficial additions to AECOPD prevention strategies, as could the inclusion of family or significant others in wellbeing plans.
- Open Access
- 1 March 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 317-325
Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
Purpose: Few interventions improve outcomes for people with Chronic Obstructive Pulmonary Disease (COPD), particularly higher risk groups such as those admitted to hospital with an acute exacerbation of COPD (AECOPD). The aim of the study was to test the feasibility and acceptability of a modified version of the Take Charge program in people after AECOPD and to determine the potential to improve self-reported limitations, health-related quality of life and reduce future hospitalizations. Patients and Methods: A prospective, parallel group randomized trial with blinded endpoint assessment. Participants had been discharged from hospital with a diagnosis of AECOPD and were randomized to receive either a single 60– 90 minute session of “Take Charge for COPD” from a trained facilitator in their own home or usual care. Take Charge is a “talking therapy” that encourages a sense of purpose, autonomy, mastery, and connectedness with others. The primary outcome was the rate of moderate or severe episodes of AECOPD in the subsequent 12 months. Results: Fifty-six people were randomized (study target 60): predominantly European (71%), female (61%), older (mean [SD] age 70 [11] years), and non-smokers (89%). Charlson Comorbidity Index mean (SD) score was 2.3 (1.6) indicating mild to moderate comorbidity severity. There were 85 moderate or severe AECOPD episodes in the 12 months after the index admission for the Take Charge participants and 84 episodes in the control group (relative rate 0.93; 95% confidence interval (CI) 0.69 to 1.26). COPD Clinical Questionnaire (CCQ) scores were significantly lower (better) in the Take Charge group (mean difference − 1.26; 95% CI − 2.06 to − 0.45). Conclusion: The Take Charge intervention proved feasible with a population of people recently discharged from hospital with AECOPD. The direction of change in the primary outcome and some secondary outcomes suggest that an adequately powered study is justified.
- 1 March 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 317-325
Open AccessTaking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention
Purpose: Few interventions improve outcomes for people with Chronic Obstructive Pulmonary Disease (COPD), particularly higher risk groups such as those admitted to hospital with an acute exacerbation of COPD (AECOPD). The aim of the study was to test the feasibility and acceptability of a modified version of the Take Charge program in people after AECOPD and to determine the potential to improve self-reported limitations, health-related quality of life and reduce future hospitalizations. Patients and Methods: A prospective, parallel group randomized trial with blinded endpoint assessment. Participants had been discharged from hospital with a diagnosis of AECOPD and were randomized to receive either a single 60– 90 minute session of “Take Charge for COPD” from a trained facilitator in their own home or usual care. Take Charge is a “talking therapy” that encourages a sense of purpose, autonomy, mastery, and connectedness with others. The primary outcome was the rate of moderate or severe episodes of AECOPD in the subsequent 12 months. Results: Fifty-six people were randomized (study target 60): predominantly European (71%), female (61%), older (mean [SD] age 70 [11] years), and non-smokers (89%). Charlson Comorbidity Index mean (SD) score was 2.3 (1.6) indicating mild to moderate comorbidity severity. There were 85 moderate or severe AECOPD episodes in the 12 months after the index admission for the Take Charge participants and 84 episodes in the control group (relative rate 0.93; 95% confidence interval (CI) 0.69 to 1.26). COPD Clinical Questionnaire (CCQ) scores were significantly lower (better) in the Take Charge group (mean difference − 1.26; 95% CI − 2.06 to − 0.45). Conclusion: The Take Charge intervention proved feasible with a population of people recently discharged from hospital with AECOPD. The direction of change in the primary outcome and some secondary outcomes suggest that an adequately powered study is justified.
- 20 December 2022
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 37 (7) , 975-985
A cohesive, person-centric evidence-based model for successful rehabilitation after stroke and other disabling conditions
- 20 December 2022
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 37 (7) , 975-985
A cohesive, person-centric evidence-based model for successful rehabilitation after stroke and other disabling conditions